Review: GAO Report on FDA and Economically Motivated Adulteration

Review: GAO Report on FDA and Economically Motivated AdulterationBy •

This a review and application of  the June 2011 publication by the U.S. Government Accountability Office (Gao), Government Accountability Office, report on “Better Coordination Could Enhance Efforts to Address Economic Adulteration and Protect the Public Health.” To note, was published by GAO one month before our journal article […]

Review: GAO Report on FDA and Economically Motivated Adulteration Read More »